Skip to main content

Table 2 Initial DTC stage and response to treatment of acromegalic patients

From: Acromegaly and thyroid cancer: analysis of evolution in a series of patients

Stage
I 19/24 (79%)
 II 4/24 (17%)
 IVb 1/24 (4%)
Initial RR
Low 21/24 (87%)
 Intermediate 2/24 (9%)
 High 1/24 (4%)
Initial response
Excellent 12/23 (52%)
 Indeterminate 7/23 (31%)
 Biochemical incomplete 3/23 (13%)
 Structural incomplete 1/23 (4%)
RFU
No evidence of disease 19/23 (83%)
 Indeterminate 2/23 (9%)
 Biochemical incomplete 1/23 (4%)
 Structural incomplete 1/23 (4%)
  1. RR recurrence risk, RFU response at the end of follow-up